http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2770267-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcfea7bbbc4a634bc37ca8e1feae7cf2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-02 |
| filingDate | 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01fd0cf8ce454d982f132092f8083399 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_842bbb567b001ae0fbaae13772505f3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c8b9b8b7e7303ece3ec3a9aae942eb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d29571278c38fb39d5f1aa9f6251df9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe84921a1d3332fc527ae5ec06211ec0 |
| publicationDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2770267-C1 |
| titleOfInvention | Method for prediction of risk of developing ventricular tachycardia in patients with postinfarction cardiosclerosis and left ventricular ejection fraction less than 35 % |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to cardiology. Blood serum ST-2 level is measured in the patients. Then, a prognostic coefficient of risk of developing ventricular tachycardia is calculated by formula. Formula is calculated using blood ST-2 values. If the prognostic coefficient according to the blood serum ST-2 level is more than 0.1502, the patient has a high risk of developing paroxysmal ventricular tachycardia.EFFECT: method enables increasing the effectiveness of the antiarrhythmic therapy in the patients with a high risk of developing ventricular tachycardia, and also allows to optimize selection of patients-candidates for implantation of cardioverter-defibrillator, which will reduce the number of irrationally implanted devices, thereby improving the quality of life of patients and optimizing economic costs.1 cl, 5 ex, 2 tbl, 1 dwg |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2804657-C1 |
| priorityDate | 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.